Nav: Home

Prescribing rates for anxiety and sleeping drugs highest in deprived areas

October 22, 2019

Prescriptions for drugs to treat anxiety, alcohol withdrawal and sleep problems are highest in the most deprived areas in England, according to a new study from the University of Warwick.

The specific group of drugs known as benzodiazepines and Z-drugs are often prescribed as sedation, to treat people with anxiety or as sleeping tablets. They can be commonly prescribed but usually for only for a short period of time to get a patient past an initial period of need.

A new study led by researchers from Warwick Medical School and published today (22 October) in the journal Family Practice has analysed the rate of prescribing of these drugs in GP practices in England in 2017, and compared this to the estimated level of socioeconomic deprivation for each of these practices.

The study found:
  • A clear association between benzodiazepine and Z-drug prescribing in GP practices and socioeconomic deprivation, with more prescribing in practices that had patients from more deprived areas. This association persisted even after accounting for the age and sex demographic differences between GP practices' patients.

  • In 2017, over 14 million prescriptions for benzodiazepines and Z-drugs were written in England, totalling the equivalent of more than 2 billion milligrams of diazepam.
  • Large geographical variation in England, with a tendency for higher prescribing rates to be seen in coastal regions, which may be due to the older demographic in those regions

    The researchers used prescribing data from GP practices in England from NHS Digital for the year 2017 and compared this with practice-level Index of Multiple Deprivation scores from Public Health England and demographics for each practice from NHS Digital. The Index of Multiple Deprivation score is an overall measure of deprivation experienced by people living in a certain area, and considers seven dimensions: income deprivation; employment deprivation; health deprivation and disability; education; skills and training deprivation; barriers to housing and services; and living environment deprivation and crime.

    They found that the rate of prescribing of benzodiazepines and Z-drugs was on average significantly (45%) higher in the most deprived GP practice populations compared to the least deprived (288 prescriptions per 1000 patients versus 198 prescriptions per 1000 patients in 2017).

    Lead author Dr Saran Shantikumar, from Warwick Medical School, said: "The key result we found was there was an association between the amount of benzodiazepines prescribed in GP practices and the level of deprivation of people served by that practice.

    "However, this is a very broad association. What we can't tell from our analysis is which people within a given practice are getting those prescriptions. In fact, a recent report from Public Health England suggested that, if anything, individual patients from the least deprived practices were more likely to be prescribed these drugs. So we're left with a conundrum: if fewer patients from the most deprived practices are being prescribed benzodiazepines, why do they tend to be prescribed higher volumes of them?

    "One possibility is that the reasons for prescribing are systematically different between practices with high or low deprivation, and that those in more deprived practices are more likely to be given repeat prescriptions. Our finding that the relationship between deprivation and prescribing varied with different benzodiazepines lends some credence to that hypothesis.

    "What clinicians can do is be aware that they may have patients who have been on these tablets for a long time and are potentially at risk, so it is worth actively thinking about whether a patient needs to continue taking those tablets or if there are alternative strategies."

    It is estimated that around 300,000 people in the UK are on long-term prescriptions for benzodiazepines or Z-drugs1, and a recent report from Public Health England found that 1.4 million people in England received a benzodiazepine prescription last year2. Often, those who are prescribed them as sleeping tablets are older people, but those who receive them for anxiety or alcohol control could be any age, and they are occasionally prescribed for acute back pain in younger people.

    Problems develop when patients are taking them for a longer period of time; specifically dependency and addiction. They can also cause adverse effects. Benzodiazepines have been associated with an increased risk of falls, traffic accidents due to an impaired ability to drive, accidental overdose, impaired cognition and dementia. These effects are particularly marked in older people.

    Dr Shantikumar adds: "It is hard to quantify how much of a problem benzodiazepine addiction is because it's not well publicised. The recent PHE report has confirmed that lots of people are taking benzodiazepines, a small number of whom have been prescribed them for some time. From my experience and others in clinical practice we know that there are people who have been taking these drugs for a long time who are struggling to get off them. Often people think that developing addiction to tablets is a silent problem, but due to the side effects it can manifest as physical problems for individuals themselves and to others.

    "Ultimately, we'd like to specifically identify the individual and GP practice characteristics which may be the driving factors behind long-term benzodiazepine use. Ideally, GPs would be supported to identify long-term users systematically and to provide alternative management options to reduce their risk of side-effects and dependence.

    "I would encourage anyone affected by, or concerned about, medication dependence to see their GP who can help discuss the problem and consider alternative treatments. The Frank website is also a fantastic source of information and local services, and have a 24-hour hotline you can call for confidential advice."
    'Socioeconomic status and benzodiazepine and Z-drug prescribing: a cross-sectional study of practice-level data in England' is published in Family Practice, DOI: 10.1093/fampra/cmz054

    Notes to editors:

    Download a map illustrating geographical variation in the prescribing rate of benzodiazepines and Z-drugs across England in 2017 by Clinical Commissioning Group:

    For interviews or a copy of the paper contact:

    Peter Thorley
    Media Relations Manager (Warwick Medical School and Department of Physics) | Press & Media Relations | University of Warwick
    Tel: +44 (0)24 761 50868
    Mob: +44 (0) 7824 540863


    1. Davies J, Rae TC, Montagu L. Long-term benzodiazepine and Z-drugs use in England: a survey of general practice. Br J Gen Pract. 2017;67(662):e609-e613.

    2. Taylor S, Annand F, Burkinshaw P, Greaves F, Kelleher M, Knight J, Perkins C, Tran A, White M, Marsden J. Dependence and withdrawal associated with some prescribed medicines: an evidence review. Public Health England, London. 2019.

    University of Warwick

    Related Sleep Problems Articles:

    Ethnically diverse mothers, children living in poverty at risk for sleep problems
    African-American and other ethnically diverse mothers know the value of a good night's sleep, but they and their young children are at risk for developing sleep problems if they live in urban poverty, a Rutgers study finds.
    Poor mental and physical health in pregnancy linked to infant sleep problems
    Severe and persistent infant sleep problems in the first year are linked to poor maternal mental and physical health during pregnancy, a new study by the Murdoch Children's Research Institute has found.
    Sleep problems in teenagers reversed in just one week by limiting screen use
    Sleep in teenagers can be improved by just one week of limiting their evening exposure to light-emitting screens on phones, tablets and computers, according to findings to be presented in Lyon, at the European Society of Endocrinology annual meeting, ECE 2019.
    Study links gene to sleep problems in autism
    Research conducted by a team of Washington State University researchers has found that sleep problems in patients with autism spectrum disorder may be linked to a mutation in the gene SHANK3 that in turn regulates the genes of the body's 24-hour day and night cycle.
    Sleep problems, Alzheimer's disease are linked, but which comes first?
    A new article explores the pathophysiological factors that link sleep disturbances and Alzheimer's disease.
    Physical activity in the evening does not cause sleep problems
    Contrary to popular belief, there is no reason to avoid exercising in the evening, an analysis of the scientific literature has revealed.
    Study reveals sleep problems in young adult students
    A study published in the Journal of Sleep Research indicates that sleep problems are both prevalent and increasing among students.
    Double whammy for grieving spouses with sleep problems
    Sleep disturbances have a strong negative impact on the immune system of people who have recently lost a spouse, reports a new study.
    Shedding light on new treatment options for perimenopausal depression and sleep problems
    Light therapy has long been a recognized treatment option for depression.
    Prostate problems also associated with sleep disorders and depression
    Men who suffer from urological problems such as erectile dysfunction, urinary tract and bladder problems or infertility issues often also suffer from depression and sleep disorders.
  • Top Science Podcasts

    We have hand picked the top science podcasts of 2019.
    Now Playing: TED Radio Hour

    In & Out Of Love
    We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
    Now Playing: Science for the People

    #542 Climate Doomsday
    Have you heard? Climate change. We did it. And it's bad. It's going to be worse. We are already suffering the effects of it in many ways. How should we TALK about the dangers we are facing, though? Should we get people good and scared? Or give them hope? Or both? Host Bethany Brookshire talks with David Wallace-Wells and Sheril Kirschenbaum to find out. This episode is hosted by Bethany Brookshire, science writer from Science News. Related links: Why Climate Disasters Might Not Boost Public Engagement on Climate Change on The New York Times by Andrew Revkin The other kind...
    Now Playing: Radiolab

    An Announcement from Radiolab